% | $
Quotes you view appear here for quick access.

Peregrine Pharmaceuticals, Inc. Message Board

  • davidf104 davidf104 Feb 14, 2013 12:28 PM Flag

    Investors Will Come To Understand It Was Great News....Eventually

    Patients, physicians, and everyone with common sense figured it out yesterday.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • I was positive when I saw the news, but at this point, be careful when I read about the detail report.
      I don;t think that PPHM has good management to perform clinic trials!! Wasted too much of our money, and provided meningless data! Clueless about this drug Bravi..

    • please list the reasons

      • 5 Replies to evora2011
      • evora2011: Your to naive to see the list of reasons what PPHM has in their hands...for hard to treat PC cancer...There are few drug companies who can create a drug product to be safe and control late stage PC cancer, even if its a for few days or weeks. or months......only 1% survive PC ....2 past friends had PC saw what they had to go through.

        PPHM has the drug! PPHM can work with and adjust to recreate future positive results with a larger trial..
        PPHM can also have trials working with early stage PC and so on... This is only the beginning....of what PPHM will or can do.

        Investors Will Come To Understand It Was Great News....Eventually
        evora2011 by evora2011 . 44 minutes ago .
        Please list the reasons

        Sentiment: Strong Buy

      • Evora -

        go read the post by PLAINTALK62 and a response to it under same post by LAUJHAWJ...

        Its easy to find... it has at least 10 replies so far...

        Sentiment: Strong Buy

      • It doubled tumor response rate. This method of action was not enough to provide a statistically significant extension of life in patients with STAGE IV PANCREATIC CANCER. BAVI does, however, have an effect on solid tumor mass. The molecule has value. We wait for confirmation of the 2nd line NSCLC. We wait for 1st line NSCLC (this is the trial that will show what Bavituximab can do when the cancer is caught early enough, as I understand it).

      • Response rate improvement was remarkable. Remember the type of cancer we are talking about here and the stage.

        They don't need to "cure" every form of cancer to be a winner.

        Looks like a handful of investors have figured it out over the past hour or so. Unfortunately the return of shorty and OE will muddy the waters again tomorrow.

        Sentiment: Strong Buy

      • Do your own DD.

        Sentiment: Strong Buy

0.40-0.01(-2.32%)9:50 AMEDT